Faculty, Staff and Student Publications

Language

English

Publication Date

7-23-2025

Journal

JACC: Case Reports

DOI

10.1016/j.jaccas.2025.104136

PMID

40713114

PMCID

PMC12441545

PubMedCentral® Posted Date

7-23-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Background: Pulmonary hypertension (PH) has rarely been associated with myeloproliferative neoplasms (MPNs), classified as World Health Organization group 5 PH. Progression of MPN may result in acute myelogenous leukemia (AML).

Case summary: We describe a young woman with AML arising from MPN presenting with PH. Both the AML and PH were alleviated with pulmonary vasodilators and chemotherapy. The patient eventually underwent allogeneic hematopoietic stem cell transplantation, achieving remission. Several months later, she presented with respiratory symptoms and worsening of PH, signaling the relapse of her AML, subsequently confirmed with right heart catheterization and bone marrow biopsies.

Discussion: Our case highlights the interplay between PH and hematologic malignancies. Literature suggests that PH progression may parallel the progression of MPN.

Take-home messages: Prompt recognition of PH in those with MPNs is needed to facilitate appropriate interventions in a multidisciplinary manner. Although an association between PH and MPN exists, further studies into the underlying mechanisms and their interplay is needed.

Keywords

acute myelogenous leukemia, myeloproliferative disease, pulmonary hypertension

Published Open-Access

yes

ga1 (1).jpg (282 kB)
Graphical Abstract

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.